FGFR1 and breast carcinoma: In another study, FGFR1-amplified tumors had increased expression of genes integral to cell cycle progression in ER+ endocrine-resistant breast cancer, and suggest that FGFR1 amplification promotes cancer cell growth and endocrine resistance [35].